Moreover, adding a cytotoxic chemotherapy, such as pemetrexed, carboplatin or paclitaxel, to EGFR‐TKIs showed clinical improvement in patients with NSCLC.5, 7, 17. This evidence concerns the gene EGFR and non-small cell lung carcinoma.